1. Home
  2. PRAX vs GETY Comparison

PRAX vs GETY Comparison

Compare PRAX & GETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • GETY
  • Stock Information
  • Founded
  • PRAX 2015
  • GETY 1995
  • Country
  • PRAX United States
  • GETY United States
  • Employees
  • PRAX N/A
  • GETY N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • GETY Industrial Machinery/Components
  • Sector
  • PRAX Health Care
  • GETY Industrials
  • Exchange
  • PRAX Nasdaq
  • GETY Nasdaq
  • Market Cap
  • PRAX 1.2B
  • GETY 1.3B
  • IPO Year
  • PRAX 2020
  • GETY N/A
  • Fundamental
  • Price
  • PRAX $74.92
  • GETY $4.02
  • Analyst Decision
  • PRAX Strong Buy
  • GETY Strong Buy
  • Analyst Count
  • PRAX 9
  • GETY 4
  • Target Price
  • PRAX $144.11
  • GETY $5.55
  • AVG Volume (30 Days)
  • PRAX 295.5K
  • GETY 259.1K
  • Earning Date
  • PRAX 11-05-2024
  • GETY 11-12-2024
  • Dividend Yield
  • PRAX N/A
  • GETY N/A
  • EPS Growth
  • PRAX N/A
  • GETY N/A
  • EPS
  • PRAX N/A
  • GETY 0.09
  • Revenue
  • PRAX $1,771,000.00
  • GETY $906,656,000.00
  • Revenue This Year
  • PRAX N/A
  • GETY $3.89
  • Revenue Next Year
  • PRAX N/A
  • GETY $3.04
  • P/E Ratio
  • PRAX N/A
  • GETY $43.89
  • Revenue Growth
  • PRAX 20.97
  • GETY N/A
  • 52 Week Low
  • PRAX $13.01
  • GETY $2.88
  • 52 Week High
  • PRAX $75.73
  • GETY $5.77
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 71.35
  • GETY 69.03
  • Support Level
  • PRAX $60.73
  • GETY $3.59
  • Resistance Level
  • PRAX $65.87
  • GETY $3.82
  • Average True Range (ATR)
  • PRAX 3.85
  • GETY 0.12
  • MACD
  • PRAX 1.22
  • GETY 0.03
  • Stochastic Oscillator
  • PRAX 96.03
  • GETY 91.58

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc is engaged in the core mission of bringing the world's creative and editorial visual content solutions to its customers to engage their audiences. the company has developed market enhancements across e-commerce, content subscriptions, user-generated content, diverse and inclusive content, and proprietary research alongside investment in its technology platform, which includes artificial intelligence and machine learning-driven search functionality and image editing and integrated APIs, to become a trusted industry leader in the visual content. Geographically the company operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific, out of which a majority of its revenue is generated from the Americas.

Share on Social Networks: